The protoMIRAX Hard X-ray Imaging Balloon Experiment

The protoMIRAX hard X-ray imaging telescope is a balloon-borne experiment developed as a pathfinder for the MIRAX satellite mission. The experiment consists essentially in a coded-aperture hard X-ray (30-200 keV) imager with a square array (13$\times$13) of 2mm-thick planar CZT detectors with a total area of 169 cm$^2$. The total, fully-coded field-of-view is $21^{\circ}\times 21^{\circ}$ and the angular resolution is 1$^{\circ}$43'. In this paper we describe the protoMIRAX instrument and all the subsystems of its balloon gondola, and we show simulated results of the instrument performance. The main objective of protoMIRAX is to carry out imaging spectroscopy of selected bright sources to demonstrate the performance of a prototype of the MIRAX hard X-ray imager. Detailed background and imaging simulations have been performed for protoMIRAX balloon flights. The 3$\sigma$ sensitivity for the 30-200 keV range is ~1.9 $\times$ 10$^{-5}$ photons cm$^{-2}$ s$^{-1}$ for an integration time of 8 hs at an atmospheric depth of 2.7 g cm$^{-2}$ and an average zenith angle of 30$^{\circ}$. We have developed an attitude control system for the balloon gondola and new data handling and ground systems that also include prototypes for the MIRAX satellite. We present the results of Monte Carlo simulations of the camera response at balloon altitudes, showing the expected background level and the detailed sensitivity of protoMIRAX. We also present the results of imaging simulations of the Crab region. The results show that protoMIRAX is capable of making spectral and imaging observations of bright hard X-ray source fields. Furthermore, the balloon observations will carry out very important tests and demonstrations of MIRAX hardware and software in a near space environment.Comment: 9 pages, 13 figures, accepted for publication in Astronomy & Astrophysic

“PROTÓTIPO DE UM SISTEMA ESPECIALISTA PARA CLASSIFICAR O NÍVEL DE COMPETITIVIDADE DE UMA MICROEMPRESA DE SERVIÇOS”

The article manages with the development of a prototype of an expert system to classify the level of competitiveness of a service microenterprise and explores concepts and applications of Artificial Intelligence (AI) and Expert Systems (ES), to assist the field of Administration in the evaluation of microenterprise management in light of the application of the Resource-Based Vision (RBV) theory, which explains the microenterprise's competitive advantage, based on its distinctive resources and competences, with the aim of creating a base of knowledge to be submitted to the expert system (ES) of competence assessment developed and, therefore, to achieve the desired results according to the VRIO methodology of Barney and Hesterly (2007). The research was carried out in a microenterprise in the Federal District (DF), based on the aforementioned methodology, which analyzes the microenterprise's competitive differential according to the premises of value, rarity, difficulty to be imitated and organizationally irreplaceableO artigo trata do desenvolvimento de um protótipo de um sistema especialista para classificar o nível de competitividade de uma microempresa de serviços e explora conceitos e aplicações de Inteligência Artificial (IA) e Sistemas Especialistas (SE), para auxiliar o campo da Administração na avalição da gestão de microempresa à luz da aplicação da teoria da Visão Baseada em Recursos (RBV - Resource-Based Vision), pela qual se explica a vantagem competitiva da empresa, baseando-se nos recursos e competências distintivas, com o objetivo de criar uma base de conhecimento para ser submetida ao sistema especialista (SE) de avaliação de competências desenvolvido e, por conseguinte, alcançar os resultados pretendidos consoante a metodologia VRIO de Barney e  Hesterly (2007). A pesquisa foi realizada numa microempresa do Distrito Federal (DF), com base na metodologia mencionada, que analisa o diferencial competitivo da empresa segundo as premissas de valor, raridade, dificuldade para ser imitado e organizacionalmente insubstituível

A Vaccine Based on Kunitz-Type Molecule Confers Protection Against Fasciola hepatica Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production

Fasciola hepatica is helminth parasite found around the world that causes fasciolosis, a chronic disease affecting mainly cattle, sheep, and occasionally humans. Triclabendazole is the drug of choice to treat this parasite. However, the continuous use of this drug has led to the development of parasite resistance and, consequently, the limitation of its effectiveness. Hence, vaccination appears as an attractive option to develop. In this work, we evaluated the potential of F. hepatica Kunitz-type molecule (FhKTM) as an antigen formulated with a liquid crystal nanostructure formed by self-assembly of 6-O-ascorbyl palmitate ester (Coa-ASC16) and the synthetic oligodeoxynucleotide containing unmethylated cytosine-guanine motifs (CpG-ODN) during an experimental model of fasciolosis in mice, and we further dissected the immune response associated with host protection. Our results showed that immunization of mice with FhKTM/CpG-ODN/Coa-ASC16 induces protection against F. hepatica challenge by preventing liver damage and improving survival after F. hepatica infection. FhKTM/CpG-ODN/Coa-ASC16-immunized mice elicited potent IFN-γ and IL-17A with high levels of antigen-specific IgG1, IgG2a, and IgA serum antibodies. Strikingly, IL-17A blockade during infection decreased IgG2a and IgA antibody levels as well as IFN-γ production, leading to an increase in mortality of vaccinated mice. The present study highlights the potential of a new vaccine formulation to improve control and help the eradication of F. hepatica infection, with potential applications for natural hosts such as cattle and sheep.Fil: Silvane, Leonardo. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Celias, Daiana Pamela. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Romagnoli, Pablo Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Grupo Vinculado Centro de Investigación en Medicina Traslacional Severo R. Amuchástegui - Cimetsa | Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Grupo Vinculado Centro de Investigación en Medicina Traslacional Severo R. Amuchástegui - Cimetsa | Instituto de Investigación Médica Mercedes y Martín Ferreyra. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Grupo Vinculado Centro de Investigación en Medicina Traslacional Severo R. Amuchástegui - Cimetsa.; Argentina. Instituto Universitario de Ciencias Biomédicas de Córdoba; ArgentinaFil: Maletto, Belkys Angélica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Sánchez Vallecillo, María Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; ArgentinaFil: Chiapello, Laura Silvina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Palma, Santiago Daniel. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Allemandi, Daniel Alberto. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Sanabria, Rodrigo Eduardo Fabrizio. Universidad Nacional de La Plata. Facultad de Ciencias Veterinarias; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús). Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas. Instituto de Investigaciones Biotecnológicas "Dr. Raúl Alfonsín" (sede Chascomús); ArgentinaFil: Pruzzo, Cesar Ivan. Universidad Nacional de La Plata. Facultad de Ciencias Veterinarias; ArgentinaFil: Motran, Claudia Cristina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Cervi, Laura Alejandra. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentin

Socio-environmental impacts of non-native and transplanted aquatic mollusc species in South America: What do we really know?

The impacts of biological invasions remain poorly known for some habitats, regions and taxa. To date, there has been no comprehensive effort to review and synthesize the impacts of invasive mollusc species in South America. In this paper, we provide a synoptic view on what is known on documented socio-ecological impacts of aquatic no-native mollusc species (NNMS) and transplanted mollusc species (TMS) from South America. An expert group involving malacologists and taxonomists from different countries, the “South America Alien Molluscs Specialists” (eMIAS), shared and summarized the scientific literature, databases, and published and unpublished information on confirmed impacts of NNMS and TMS in South America. Three broad categories, non-mutually exclusive were used as a framework: “Environmental/Biodiversity impacts”, “Economic and social effects”, and “Human health impacts”. Some 21 NNMS and seven TMS have documented impacts on at least one of those three categories. We encourage targeting the less known areas of research, such as economic valuation of human health (and veterinary) impacts attributable to NNMS or TMS and expand our knowledge of environmental impacts for the species listed in this study.Fil: Carranza, Alvar. Universidad de la República; Uruguay. Museo Nacional de Historia Natural Uruguay; UruguayFil: Agudo Padrón, Ignacio. Projeto “avulsos Malacológicos”; BrasilFil: Collado, Gonzalo A.. Universidad del Bio Bio; Chile. Sociedad Malacológica Chile; ChileFil: Damborenea, Maria Cristina. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. División Zoología Invertebrados; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; ArgentinaFil: Fabres, Alejandra. Sociedad Malacológica Chile; Chile. Universidad Católica de Maule; ChileFil: Gutierrez Gregoric, Diego Eduardo. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. División Zoología Invertebrados; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; ArgentinaFil: Lodeiros, Cesar. Universidad Técnica de Manabí; Ecuador. Universidad de Oriente; VenezuelaFil: Ludwig, Sandra. Universidade Federal de Minas Gerais; BrasilFil: Pastorino, Roberto Santiago Guido. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Museo Argentino de Ciencias Naturales "Bernardino Rivadavia"; ArgentinaFil: Penchaszadeh, Pablo Enrique. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Museo Argentino de Ciencias Naturales "Bernardino Rivadavia"; ArgentinaFil: Salvador, Rodrigo B.. Museum of New Zealand Te Papa Tongarewa,; Nueva Zelanda. The Artic University of Norway; NoruegaFil: Spotorno, Paula. Universidade Federal do Rio Grande; BrasilFil: Thiengo, Silvana. Fundación Oswaldo Cruz; BrasilFil: Vidigal, Teofania Heloisa Dutra Amorim. Universidade Federal de Minas Gerais; BrasilFil: Darrigran, Gustavo Alberto. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. División de Zoología Invertebrados; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentin

Análise da eficiência da diatomita no tratamento de fluido sintético oleoso, visando aplicação em água produzida em campos de petróleo / Efficiency analysis of diatomite in the treatment of oily synthetic fluid, aiming at application in oil field produced water

Em campos maduros de petróleo é produzido um volume elevado de água como resíduo. O gerenciamento dessa água produzida é um grande desafio para as empresas petrolíferas e, em virtude das grandes quantidades de contaminantes tóxicos, a mesma deve ser rigorosamente tratada com a finalidade de atender as exigências ambientais antes de ser encaminhada ao seu destino final. Diversas técnicas para tratar a água produzida vêm sendo desenvolvidas e a adsorção tem ganhado bastante destaque nesses estudos por apresentar bons resultados. Este trabalho teve como objetivo analisar a utilização da diatomita na forma natural e hidrofobizada como adsorventes para remoção de hidrocarbonetos em fluido sintético. Os materiais foram caracterizados pelas técnicas de termogravimetria e de espectroscopia de absorção na região do infravermelho por transformada de Fourier-FTIR, e através dos resultados obtidos foi verificado que o processo de hidrofobização da diatomita ocorreu corretamente. Para o estudo da eficiência dos materiais no processo de adsorção, um volume fixo de fluido sintético foi posto em contato com os adsorventes sob agitação, amostras foram recolhidas durante os testes experimentais para analisar a sua turbidez e massa específica. Verificou-se que a diatomita hidrofobizada apresentou uma remoção de turbidez nos fluidos acima de 43%, porém, o material natural mostrou uma eficiência maior para essa remoção, superior a 90%. Após o contato com os adsorventes, a massa específica dos fluidos aumentou para valores um pouco superiores ao da água, sugerindo que os hidrocarbonetos foram adsorvidos. Portanto, a diatomita apresenta bom potencial para ser utilizada no tratamento de água produzida. 

AÇÃO ANTIFÚNGICA DE UM JATO DE PLASMA NÃO-TERMICO DE HÉLIO/AR COMPRIMIDO SOBRE BIOFILMES DE CANDIDA ALBICANS

Os biofilmes fúngicos são uma predominante causa de infecções crônicas associadas à utilização de cateteres e próteses, conferindo resistência aos antibióticos e fatores imunológicos do hospedeiro, sendo as leveduras, do gênero Candida spp, as mais frequentemente isoladas. O plasma não-térmico, operado à pressão atmosférica, vem ganhando destaque como uma nova estratégia antimicrobiana, inclusive para erradicação de biofilmes. Este trabalho teve como objetivo avaliar a eficácia da inativação de biofilmes de Candida albicans ATCC sobre substrato de poliuretano, utilizando jatos de plasma atmosférico de 6L/min de hélio e 4L/min de ar comprimido, alternando entre sistema contínuo e pulsado, com frequência de 60Hz e distâncias de 10 a 30mm entre o bocal e substrato. Após tratamento, realizou-se a contagem das unidades formadoras de colônia e a análise morfológica da superfície do biofilme por Microscopia Eletrônica de Varredura. O melhor grupo foi o plasma de modo pulsado com distância de 30mm com redução de 92% das unidades formadoras de colônia, demonstrando ser uma tecnologia promissora para o controle de biofilmes de C. albicans

Brazilian guidelines on chronic venous disease of the Brazilian Society of Angiology and Vascular Surgery

Abstract The Brazilian Society of Angiology and Vascular Surgery has set up a committee to provide new evidence-based recommendations for patient care associated with chronic venous insufficiency. Topics were divided in five groups: 1. Classification, 2. Diagnosis, 3. Conservative or non-invasive treatment, 4. Invasive treatment and 5. Treatment of small vessels. This last series is closely related to the activities of Brazilian angiologists and vascular surgeons, who are heavily involved in the treatment of small superficial veins. These guidelines are intended to assist in clinical decision-making for attending physicians and health managers. The decision to follow a guideline recommendation should be made by the responsible physician on a case-by-case basis taking into account the patient's specific condition, as well as local resources, regulations, laws, and clinical practice recommendations

Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI : Results of the ISACS-STEMI COVID-19 Registry

Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of the current analysis is to evaluate the age-related effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI within the registry ISACS-STEMI COVID-19. Methods: This retrospective multicenter registry was performed in high-volume PPCI centers on four continents and included STEMI patients undergoing PPCI in March–June 2019 and 2020. Patients were divided according to age (< or ≥75 years). The main outcomes were the incidence and timing of PPCI, (ischemia time longer than 12 h and door-to-balloon longer than 30 min), and in-hospital or 30-day mortality. Results: We included 16,683 patients undergoing PPCI in 109 centers. In 2020, during the pandemic, there was a significant reduction in PPCI as compared to 2019 (IRR 0.843 (95%-CI: 0.825–0.861, p < 0.0001). We found a significant agerelated reduction (7%, p = 0.015), with a larger effect on elderly than on younger patients. Furthermore, we observed significantly higher 30-day mortality during the pandemic period, especially among the elderly (13.6% vs. 17.9%, adjusted HR (95% CI) = 1.55 [1.24–1.93], p < 0.001) as compared to younger patients (4.8% vs. 5.7%; adjusted HR (95% CI) = 1.25 [1.05–1.49], p = 0.013), as a potential consequence of the significantly longer ischemia time observed during the pandemic. Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures, with a larger reduction and a longer delay to treatment among elderly patients, which may have contributed to increase in-hospital and 30-day mortality during the pandemic

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

Background. Several reports have demonstrated the impact of the COVID-19 pandemic on the management and outcome of patients with ST-segment elevation myocardial infarction (STEMI). The aim of the current analysis is to investigate the potential gender difference in the effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI patients within the ISACS-STEMI COVID-19 Registry. Methods. This retrospective multicenter registry was performed in high-volume primary percutaneous coronary intervention (PPCI) centers on four continents and included STEMI patients undergoing PPCIs in March–June 2019 and 2020. Patients were divided according to gender. The main outcomes were the incidence and timing of the PPCI, (ischemia time ≥ 12 h and door-to-balloon ≥ 30 min) and in-hospital or 30-day mortality. Results. We included 16683 STEMI patients undergoing PPCIs in 109 centers. In 2020 during the pandemic, there was a significant reduction in PPCIs compared to 2019 (IRR 0.843 (95% CI: 0.825–0.861, p < 0.0001). We did not find a significant gender difference in the effects of the COVID-19 pandemic on the numbers of STEMI patients, which were similarly reduced from 2019 to 2020 in both groups, or in the mortality rates. Compared to prepandemia, 30-day mortality was significantly higher during the pandemic period among female (12.1% vs. 8.7%; adjusted HR [95% CI] = 1.66 [1.31–2.11], p < 0.001) but not male patients (5.8% vs. 6.7%; adjusted HR [95% CI] = 1.14 [0.96–1.34], p = 0.12). Conclusions. The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures similarly observed in both genders. Furthermore, we observed significantly increased in-hospital and 30-day mortality rates during the pandemic only among females. Trial registration number: NCT 04412655

Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of the current analysis is to evaluate the age-related effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI within the registry ISACS-STEMI COVID-19. Methods: This retrospective multicenter registry was performed in high-volume PPCI centers on four continents and included STEMI patients undergoing PPCI in March-June 2019 and 2020. Patients were divided according to age (= 75 years). The main outcomes were the incidence and timing of PPCI, (ischemia time longer than 12 h and door-to-balloon longer than 30 min), and in-hospital or 30-day mortality. Results: We included 16,683 patients undergoing PPCI in 109 centers. In 2020, during the pandemic, there was a significant reduction in PPCI as compared to 2019 (IRR 0.843 (95%-CI: 0.825-0.861, p < 0.0001). We found a significant age-related reduction (7%, p = 0.015), with a larger effect on elderly than on younger patients. Furthermore, we observed significantly higher 30-day mortality during the pandemic period, especially among the elderly (13.6% vs. 17.9%, adjusted HR (95% CI) = 1.55 [1.24-1.93], p < 0.001) as compared to younger patients (4.8% vs. 5.7%; adjusted HR (95% CI) = 1.25 [1.05-1.49], p = 0.013), as a potential consequence of the significantly longer ischemia time observed during the pandemic. Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures, with a larger reduction and a longer delay to treatment among elderly patients, which may have contributed to increase in-hospital and 30-day mortality during the pandemic